Three specialized medical purpose foods developed by Kwins Health Pharmaceutical Jiangsu Co, located in the Taizhou Medical High-tech Zone in Taizhou, recently received market approval.

The 2023 Forum on the Frontier and Application Development of Vaccine Technology took place in the China Medical City in Taizhou, from July 10 to 12.

President Xi Jinping has reemphasized the importance of promoting scientific and technological self-reliance and developing the real economy in pursuing high-quality growth, during his inspection in Jiangsu.

Two enterprises in the Taizhou Medical High-tech Zone were recently recognized as provincial-level demonstration bases for employment and internship.

A signing ceremony for eight projects totaling 2.4 billion yuan ($331.50 million) took place at the port logistics industrial park in the Taizhou Medical High-tech Zone, on July 3.

The Yangtze River Pharmaceutical Group – located in the Taizhou Medical High-tech Zone – has set out on the path to planting standardized TCM crops.

Final preparations are taking place for Phase I of a new energy lithium-ion batteries and integrated storage plant – being funded by Shenghong Holding Group Co Ltd at a cost of 3 billion yuan ($418.83 million).

Huier Kangxin, a full-dose non-adjuvant vaccine by Jiangsu Ab&B Bio-Tech Co Ltd, has become the first tetravalent influenza virus subunit vaccine to receive approval for sale in China.